Source - RNS
RNS Number : 9719J
The MedicX Fund Limited
15 September 2016
 

 

 

For immediate release

15 September 2016

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

 

Block listing application

 

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, has made an application to the UK Listing Authority for a block listing, for general business purposes, of 23,981,109 ordinary shares of no par value to be admitted to The Official List of the UK Listing Authority and to trading on The London Stock Exchange's main market for listed securities.

 

Shares issued under the block listing will be used to satisfy demand that cannot be met through the secondary market and the proceeds of share issuance under the block listing will be used for investment in accordance with the Company's investment policy.

 

The block listing is expected to become effective at 8.00 a.m. on 16 September 2016.

 

 

- End -

 

 

For further information please contact:

 

MedicX Fund                                                                  +44 (0) 1481 723 450

David Staples, Chairman

 

Octopus Healthcare Group                                               +44 (0) 20 3142 4820

Mike Adams, Chief Executive Officer

 

Canaccord Genuity                                                          +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith        

 

Buchanan                                                                      +44 (0) 20 7466 5000

Charles Ryland/Vicky Hayns

 

Information on MedicX Fund Limited

 

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 152 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1 billion of healthcare investments across a number of platforms, with a focus on four core areas: GP surgeries, care homes, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £5.5 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSLLFIVARIELIR

Related Charts

MedicX Fund (MXF)

+0.50p (+0.56%)
delayed 16:57PM